Results 211 to 220 of about 2,801,899 (401)
Novel Adenosine Receptor Antagonists for Treating Cancer and Immune-Related Disorders. [PDF]
Sabnis RW.
europepmc +1 more source
Synergy between receptors mediates adenosine release from spinal cord synaptosomes
Catherine M. Cahill +2 more
openalex +2 more sources
Neuroanesthesia and Intensive Care Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists [PDF]
Yanhong Liu +3 more
openalex +1 more source
Dietary habits play a key role in chronic diseases, and higher annual consumption of fruit and vegetable may lower risk of dementia. Artificial intelligence predicts the lipid‐like compound α‐Amyrin (αA) from plants with edible peels as a drug candidate against Alzheimer's disease.
Shu‐Qin Cao +36 more
wiley +1 more source
Therapeutic potential of adenosine receptor modulators in cancer treatment. [PDF]
Maity P, Ganguly S, Deb PK.
europepmc +1 more source
Protein Kinase A and Ca<sub>v</sub>1 (L-Type) Channels Are Common Targets to Facilitatory Adenosine A<sub>2A</sub> and Muscarinic M<sub>1</sub> Receptors on Rat Motoneurons [PDF]
Laura Oliveira, Paulo Correia‐de‐Sá
openalex +1 more source
Hyaluronic acid‐modified bimetallic peroxide nanocomposites (MgO2‐CuO2@HA) are designed for synergistic tumor therapy. The nanocomposites release Mg2+, H2O2, and Cu2+ in tumor cells, induce cuproptosis via Cu+‐mediated protein aggregation, and activate pyroptosis through caspase‐1/gasdermin D pathways for inducing immunogenic cell death, collectively ...
Guanting He +8 more
wiley +1 more source
Molecular basis of ligand binding and receptor activation at the human A<sub>3</sub> adenosine receptor. [PDF]
Zhang L +10 more
europepmc +1 more source
This study systematically investigates the function and molecular mechanisms of YAP phase separation in multiple primary liver cancers. These findings provide novel insights into phase separation‐mediated primary liver cancer development and validate targeted disruption of this process as an effective therapeutic strategy for primary liver cancer ...
Shuang‐Zhou Peng +7 more
wiley +1 more source

